PHK
CNTB

Point72 Hong Kong’s Connect Biopharma Holdings CNTB Stock Holding History

Point72 Hong Kong’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,426
Closed -$193K – 1974
2021
Q1 		$193K Buy
+10,426
New +$177K 0.01% 1057

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Point72 Hong Kong's CNTB Position: Q2 2021 in Review

Point72 Hong Kong sold out of Connect Biopharma Holdings (CNTB) in Q2 2021, closing a stake of 10,426 shares — an estimated $193K sold.

Point72 Hong Kong first reported a position in CNTB in Q1 2021 and held it in 1 quarter. The position peaked at $193K in Q1 2021. 16 funds tracked by Wall St. Rank hold CNTB as of Q2 2021.

  • Point72 Hong Kong reported no remaining Connect Biopharma Holdings position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 10,426 Connect Biopharma Holdings shares in Q2 2021, an estimated $193K.
  • Point72 Hong Kong first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 1 quarter.
  • Point72 Hong Kong's Connect Biopharma Holdings position peaked at $193K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.